The secondary prevention of hepatitis B virus-associated hepatocellular carcinoma

References

[1] Hou JL.The guideline of prevention and treatment for chronic hepatitis B: a 2015 update..Zhonghua Gan Zang Bing Za Zhi2015;23:888-905(in Chinese)

[2] Tsai WL.Viral hepatocarcinogenesis..Oncogene2010;29:2309-24 PMCID:PMC3148694

[3] Saitta C,Barbera A,Smedile A.Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma..Liver Int2015;35:2311-7

[4] Kawai-Kitahata F,Tanaka S,Murakawa M.Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features..J Gastroenterol2016;51:473-86

[5] Lau CC,Ching AK,Li JW.Viral-human chimeric transcript predisposes risk to liver cancer development and progression..Cancer Cell2014;25:335-49

[6] Liang HW,Wang Y,Fu Z.Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122..J Hepatol2016;64:278-91

[7] European Association for the Study of the LiverEASL clinical practice guidelines: management of hepatocellular carcinoma..J Hepatol2018;69:182-236

[8] Sung JJ,Wong VW,Chan HL.Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma..Aliment Pharmacol Ther2008;28:1067-77

[9] Papatheodoridis G V,Touloumi G,Raptopoulou-Gigi M.Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study..Gut2011;60:1109-16

[10] Lai CL.Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy..Hepatology2013;57:399-408

[11] Yang F,Chen L,Cao GW.Anti-HBV treatment delays development and evolution of HCC..Academic Journal of Second Military Medical University2014;35:

[12] Tetsuya Hosaka, Antiviral Drug Cuts Cancer Risk in Hepatitis B, medpagetoday November 12, 2012

[13] Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study..AASLD2014;LB-30

[14] Jiang JN,Su MH,Wang BJ.The clinical outcomes of the CHB and LC patient treated with long term nucleos(t)ide analogs under whole-course management: a real-life cohort study..J Hepatol2014;60:S361-522